Answers are grounded in this paper and cite their sources.
Genetic effects on common disease are mediated through many genes in multiple cell types, yet how networks connect genome-wide genetic risk to core disease genes remains unclear. One key limitation is that disease-related gene networks are likely cell type-specific, but these are poorly captured by bulk and pseudobulk coexpression networks. Here we used population-scale single-cell immune transcriptomes to decompose interindividual gene coexpression into cell type-shared and -specific networks, which have nearly opposite properties. Shared network hubs were enriched in constrained housekeeping genes, whereas cell type-specific hubs were dynamically expressed, rapidly evolving, and enriched in cell type-matched enhancers and transcription factors. Specific hubs enriched for immune disease GWAS heritability, Mendelian genes, and drug targets; these enrichments were absent or weak for non-immune disease and shared hubs. Gene-gene network edges enriched for causal trans regulation identified by trans eQTLs and perturb-seq, with shared hubs skewed to upstream regulators and specific hubs skewed to downstream disease-proximal genes. Specific hubs increased the relative success of genetically supported immune drug targets from 1.7-fold to 2.7-fold; for example, the lupus drug target BAFF is a monocyte hub connected to the Mendelian gene TREX1 and interferon-responsive genes. Overall, accounting for shared housekeeping networks reveals that cell type-specific networks funnel genetic risk into downstream and dynamic core disease genes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: